• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Invivyd, Inc. - Common Stock (NQ:IVVD)

    1.695 +0.085 (+5.28%)
    Streaming Delayed Price Updated: 2:50 PM EST, Feb 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 755,482
    Open 1.630
    Bid (Size) 1.690 (5,400)
    Ask (Size) 1.700 (7,300)
    Prev. Close 1.610
    Today's Range 1.595 - 1.705
    52wk Range 0.4600 - 3.070
    Shares Outstanding 109,755,624
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration
    From Invivyd
    Via GlobeNewswire

    Performance

    YTD
    -32.2%
    -32.2%
    1 Month
    -17.3%
    -17.3%
    3 Month
    -29.4%
    -29.4%
    6 Month
    +202.8%
    +202.8%
    1 Year
    +36.7%
    +36.7%

    More News

    Read More
    News headline image
    Invivyd Announces Partnership with World Champion Skier Lindsey Vonn to Educate Americans on Antibodies and Disease Prevention
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd and SPEAR Study Group Announce Plan for Phase 2 Study of VYD2311 for Treatment of Long COVID and COVID Vaccine-Injured Individuals to Commence Mid-2026
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Inc (NASDAQ:IVVD) Emerges as High-Growth Momentum Leader ↗
    Via Chartmill
    News headline image
    Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness
    From Invivyd
    Via GlobeNewswire
    News headline image
    These stocks that are showing activity before the opening bell on Tuesday. ↗
    Via Chartmill
    News headline image
    Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Invivyd Stock Hits 19-Month High As Public Offering Lands Days After Point72, Janus Henderson Reveal Big Stakes ↗
    Via Stocktwits
    News headline image
    Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
    From Invivyd
    Via GlobeNewswire
    News headline image
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    Invivyd Announces Proposed Public Offering of Common Stock
    From Invivyd
    Via GlobeNewswire
    News headline image
    Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗
    Via Benzinga
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    These stocks are making the most noise in today's session. ↗
    Via Chartmill
    News headline image
    Which stocks are moving on Friday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill

    Frequently Asked Questions

    Is Invivyd, Inc. - Common Stock publicly traded?
    Yes, Invivyd, Inc. - Common Stock is publicly traded.
    What exchange does Invivyd, Inc. - Common Stock trade on?
    Invivyd, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Invivyd, Inc. - Common Stock?
    The ticker symbol for Invivyd, Inc. - Common Stock is IVVD on the Nasdaq Stock Market
    What is the current price of Invivyd, Inc. - Common Stock?
    The current price of Invivyd, Inc. - Common Stock is 1.695
    When was Invivyd, Inc. - Common Stock last traded?
    The last trade of Invivyd, Inc. - Common Stock was at 02/24/26 02:50 PM ET
    What is the market capitalization of Invivyd, Inc. - Common Stock?
    The market capitalization of Invivyd, Inc. - Common Stock is 186.04M
    How many shares of Invivyd, Inc. - Common Stock are outstanding?
    Invivyd, Inc. - Common Stock has 186M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.